Astagraf XL® (tacrolimus) – Expanded indication
November 29, 2018 - The FDA approved Astagraf XL (tacrolimus) extended-release capsules, for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants in adult and pediatric patients.
Download PDF
